Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes

Alexander  Berezin; Alexander A.  Kremzer; Tatayna A.  Samura; Yulia V.  Martovitskaya

International Cardiovascular Research Journal

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

Home

Instructions

APC

Authors Guide Submit Manuscript

Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes

Author(s):

Alexander Berezin^1,*,

Alexander A. Kremzer²,

Tatayna A. Samura²,

Yulia V. Martovitskaya³

1State Medical University, Internal Medicine Department, Zaporozhye, Ukraine

2State Medical University, Clinical Pharmacology Department, Zaporozhye, Ukraine

3State Medical University, Pathology Department, Zaporozhye, Ukraine

International Cardiovascular Research Journal:Vol. 8, issue 3; e11090

Published online:Sep 30, 2014

Article type:Research Article

Received:Feb 20, 2017

Accepted:Apr 30, 2014

How to Cite:Berezin A, Kremzer AA, Samura TA, Martovitskaya YV. Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes. Int Cardiovasc Res J. 2017;8(3):e11090. doi:

Abstract

Background: Endothelial-derived apoptotic microparticles (EMPs) play a pivotal role in endothelial dysfunction in hronic Heart Failure (CHF).

Objectives: The present study aimed to evaluate the association between EMPs and pro-inflammatory biomarkers, clinical status, and outcomes in the patients with ischemic CHF.

Patients and Methods: This study was conducted on 154 patients with ischemic symptomatic moderate-to-severe CHF on discharge from hospital. The observation period was up to 3 years. Circulating NT-pro-BNP, TNF-alpha, sFas, and sFas ligand were determined at baseline. Flow cytometry analysis was used for quantifying the number of EMPs. All-cause mortality, CHF-related death, and CHD-re-hospitalization rate were examined. The data were analyzed using descriptive statistics, Receive Operation Characteristic Curve (ROC), and logistic regression analysis. Besides, P < 0.05 was considered as statistically significant.

Results: During a median follow-up of 2.18 years, 21 participants died and 106 subjects were hospitalized repetitively. The results showed a significant difference between the patients with a large number of EMPs (> 0.514 n/mL) and those with a low level of the biomarker (< 0.514 n/mL) regarding their survival. The number of circulating EPMs independently predicted all-cause mortality (OR = 1.58; 95% CI = 1.20 – 1.88; P = 0.001), CHF-related death (OR = 1.22; 95% CI: 1.12 – 1.36; P < 0.001), and CHF-related re-hospitalization (OR = 1.20; 95% CI: 1.11 – 1.32; P < 0.001).

Conclusions: Among the patients with symptoms of CHF, increased number of circulating EMPs was associated with increased 3-year CHF-related death, all-cause mortality, and risk of recurrent hospitalization due to CHF.

Keywords

Fulltext

The full text is available in the PDF.

References

1.
The reference is available in the PDF.

Circulating Osteonectin as a Predictive Biomarker in Patients with Ischemic Symptomatic Chronic Heart Failure

Alexander Berezin,

Alexander A. Kremzer

Berezin A, Kremzer AA. Circulating Osteonectin as a Predictive Biomarker in Patients with Ischemic Symptomatic Chronic Heart Failure. Int Cardiovasc Res J. 2017;9(4):e10873. doi: https://doi.org/10.17795/icrj-9(4)203

30

Jun

2008

Association between the level of soluble markers of Fas/FasL apoptosis system and heart failure

R Najafipour,

O Pavelovna

Najafipour R, Pavelovna O. Association between the level of soluble markers of Fas/FasL apoptosis system and heart failure. J Inflamm Dis. 2024;12(1):e155378. doi:

15

Jun

2020

Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure

Maryam Nabati,

Soheil Bakhshinasab,

Ali asghar Farsavian,

Fatemeh Rasolpor,

Jamshid Yazdani- Charati

Nabati M, Bakhshinasab S, Farsavian AA, Rasolpor F, Yazdani- Charati J. Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure. Int Cardiovasc Res J. 2020;14(2):e103597. doi:

1

Dec

2019

Correlates and Prognostic Value of NT-proBNP in Post-Acute Coronary Syndrome Patients with Preserved Left Ventricular Ejection Fraction

Marta Fontes-Oliveira,

Filipe Martins,

Luis Gomes,

Maria Trepa,

Raquel Baggen-Santos,

Ricardo Costa

,et al.

Fontes-Oliveira M, Martins F, Gomes L, Trepa M, Baggen-Santos R, et al. Correlates and Prognostic Value of NT-proBNP in Post-Acute Coronary Syndrome Patients with Preserved Left Ventricular Ejection Fraction. Int Cardiovasc Res J. 2019;13(4):e96017. doi:

6

Dec

2023

The Relationship of Inflammatory Chemokine, CXCL12, with NT-proBNP: A Marker of Congestive Heart Failure in Rheumatoid Arthritis Patients

Nzar Hussein Hassan,

Afsaneh Shamsi,

Parviz Soufivand,

Fariborz Bahremand,

Mahdi Taghaddosi,

Seyed Askar Roghani

Hassan NH, Shamsi A, Soufivand P, Bahremand F, Taghaddosi M, et al. The Relationship of Inflammatory Chemokine, CXCL12, with NT-proBNP: A Marker of Congestive Heart Failure in Rheumatoid Arthritis Patients. J Kermanshah Univ Med Sci. 2023;27(4):e141254. doi: https://doi.org/10.5812/jkums-141254

Import into EndNote Import into BibTex

Share on

Comments

Number of Comments:0

Cited by

Scopus by DOI: 0
Last Update: 4 days ago
Scopus by Title: 22
Last Update: 4 days ago
Scopus by Title (Ref): 22
Last Update: 4 days ago
CrossRef: 0
Last Update: 3 days ago

Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC

Search Relations

Author(s):

Alexander Berezin:[PubMed][Scholar]
Alexander A. Kremzer:[PubMed][Scholar]
Tatayna A. Samura:[PubMed][Scholar]
Yulia V. Martovitskaya:[PubMed][Scholar]

The Official Annually Journal of Cardiovascular Research Center, Shiraz University of Medical Sciences

Outlines

Circulating Endothelial-Derived Apoptotic Microparticles in the Patients with Ischemic Symptomatic Chronic Heart Failure: Relevance of Pro-Inflammatory Activation and Outcomes

Abstract

Fulltext

References

Similar Articles

Circulating Osteonectin as a Predictive Biomarker in Patients with Ischemic Symptomatic Chronic Heart Failure

Association between the level of soluble markers of Fas/FasL apoptosis system and heart failure

Atrial Fibrillation as a Risk Marker in Patients with Decompensated Heart Failure

Correlates and Prognostic Value of NT-proBNP in Post-Acute Coronary Syndrome Patients with Preserved Left Ventricular Ejection Fraction

The Relationship of Inflammatory Chemokine, CXCL12, with NT-proBNP: A Marker of Congestive Heart Failure in Rheumatoid Arthritis Patients

Last Update: 4 days ago

Last Update: 4 days ago

Last Update: 4 days ago

Last Update: 3 days ago